June 4, 2020 / 6:04 AM / a month ago

BRIEF-Targovax Enters Collaboration With Leidos

June 4 (Reuters) - Targovax ASA:

* TARGOVAX ENTERS COLLABORATION WITH LEIDOS TO ADD CHECKPOINT INHIBITOR FUNCTIONALITY TO ONCOS VIRUSES

* UNDER AGREEMENT, LEIDOS AND TARGOVAX WILL INVESTIGATE TECHNICAL FEASIBILITY, IN VITRO AND IN VIVO IMMUNE MODULATORY, AND ANTI-CANCER PROPERTIES OF ENCODING MICROTIDE™ CHECKPOINT PEPTIDES IN ONCOS ADENOVIRUS BACKBONE

* IF SUCCESSFUL, COMBINED ONCOS AND MICROTIDE™ CONSTRUCTS MAY SERVE AS A PLATFORM WHERE ADDITIONAL FUNCTIONALITY CAN BE BUILT IN TO STIMULATE MULTIPLE COMPLEMENTARY ANTI-TUMOR MECHANISMS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below